| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |